City of Hope Scientists Report Positive Immune Response Against Mpox Using a Vaccine Developed at Its Los Angeles Campus
https://reachmd.com/news/city-of-hope-scientists-report-positive-immune-response-against-mpox-using-a-vaccine-developed-at-its-los-angeles-campus/2457434/
FINDINGSIn research led by vaccine experts at City of Hope, a novel COVID-19 vaccine candidate (COH04S1) has been found to also elicit a robust immune response to the mpox (formerly known as monkey pox) virus. Humans and nonhuman primates who received COH04S1 generated an mpox virus (MPXV) cross-…
Understanding the Role Played by HIV in Pulmonary Hypertension
https://reachmd.com/news/understanding-the-role-played-by-hiv-in-pulmonary-hypertension/2457375/
Across the globe, more than 39 million people are living with the Human Immunodeficiency Virus (HIV), the virus that causes AIDS, including more than 1.3 million new HIV diagnoses last year. The majority of those afflicted -; approximately 76% -; have access to antiviral therapy that allows the…
Almodóvar Receives NIH Grant to Study Pulmonary Hypertension in HIV Patients
https://reachmd.com/news/almodovar-receives-nih-grant-to-study-pulmonary-hypertension-in-hiv-patients/2457300/
Across the globe, more than 39 million people are living with the Human Immunodeficiency Virus (HIV), the virus that causes AIDS, including more than 1.3 million new HIV diagnoses last year. The majority of those afflicted — approximately 76% — have access to antiviral therapy that allows them to…
New Genetic Therapy Holds Promise for ALS and Frontotemporal Dementia
https://reachmd.com/news/new-genetic-therapy-holds-promise-for-als-and-frontotemporal-dementia/2457219/
image: Dr Annika van Hummel, Professor Yazi Ke and Professor Lars Ittner from Macquarie University view more Credit: Samantha Christensen Neuroscientists at Macquarie University in Australia have developed a single-dose genetic medicine that has been proven to halt the progression of both …
Secrets of Human Genetics Could Optimize Medical Care
https://reachmd.com/news/secrets-of-human-genetics-could-optimize-medical-care/2457162/
In a study that bridges human evolution and modern medicine, researchers have shed light on the genetic marvels of adaptation among high-altitude populations. The research may ultimately pave the way for innovative approaches in treating respiratory diseases.The study was led by Dr. Tatum Simonson,…
Mass General Brigham Study Highlights Varied Risk of Persistent COVID-19 Infection Among Immunocompromised Patients
https://reachmd.com/news/mass-general-brigham-study-highlights-varied-risk-of-persistent-covid-19-infection-among-immunocompromised-patients/2456980/
Patients who were severely immunocompromised were at greater risk of protracted disease and had a longer period in which they shed the virus, especially those with hematologic malignancy or transplant. While the sample size was limited, patients with mild/moderate immunosuppression had an inta…
Early HIV Treatment: Crucial Key to Remission
https://reachmd.com/news/early-hiv-treatment-crucial-key-to-remission/2456918/
People living with HIV need to take antiretroviral treatment for life to prevent the virus from multiplying in their body. But some people, known as "post-treatment controllers," have been able to discontinue their treatment while maintaining an undetectable viral load for several years. Starting…
Genetic Risk of New Cancers Among Childhood Cancer Survivors
https://reachmd.com/news/genetic-risk-of-new-cancers-among-childhood-cancer-survivors/2467184/
Genetics may one day help inform a childhood cancer survivor’s risk of subsequent cancers. Credit: iStock/Cavan Images …
Virus That Causes COVID-19 Can Remain in Sperm for 110 Days After Infection
https://reachmd.com/news/virus-that-causes-covid-19-can-remain-in-sperm-for-110-days-after-infection/2466939/
Researchers at the University of São Paulo (USP) in Brazil have shown for the first time that SARS-CoV-2, the virus that causes COVID-19, can remain in the sperm of patients for up to 90 days after hospital discharge and up to 110 days after the initial inf…
New mRNA Cancer Vaccine Triggers Fierce Immune Response to Fight Malignant Brain Tumor
https://reachmd.com/news/new-mrna-cancer-vaccine-triggers-fierce-immune-response-to-fight-malignant-brain-tumor/2462934/
In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine developed at the University of Florida quickly reprogrammed the immune system to attack glioblastoma, the most aggressive and lethal brain tumor. The results mirror those in 10 pet dog patients suffering fro…